TikoMed's ILB® mobilizes and modulates key growth facto

TikoMed's ILB® mobilizes and modulates key growth factors that trigger a cascade of neuroprotective mechanisms able to t

VIKEN, Sweden, Aug. 31, 2022 /PRNewswire/ -- TikoMed, a biopharmaceutical company focused on harnessing the...

Related Keywords

Sweden , Anders Kristensson , Ann Logan , Prnewswire Tikomed , University Of Warwick , Scientific Director , Axolotl Consulting , Regenerative Medicine , Amyotrophic Lateral Sclerosis , Traumatic Brain Injury ,